Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thrombospondin type-1 domain-containing protein 7A (THSD7A) is a large, N-glycosylated, type I membrane protein found mainly in endothelial cells, especially of the placenta and umbilical cord. It features 21 extracellular domains arranged in a pattern of TSP-1-like and F-spondin-like domains and may function as a heparan sulfate binding site. A soluble form is released via proteolytic cleavage, which promotes endothelial cell migration, filopodia formation, and tube formation during angiogenesis, primarily mediated by focal adhesion kinase (FAK) signaling and cytoskeletal rearrangement. Mutations in, or autoimmune responses to, THSD7A are implicated in idiopathic membranous nephropathy, with specific autoantibodies used as biomarkers for diagnosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thrombospondin type-1 domain-containing protein 7A (THSD7A).